ERS International Congress 2023: highlights from the Airway Diseases Assembly.

Autor:	Bergantini L; Respiratory Disease Unit, Department of Medical Sciences, Surgery, and Neurosciences, University of Siena, Siena, Italy., Baker J; Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK., Bossios A; Karolinska Severe Asthma Center, Department of Respiratory Medicine and Allergy, Karolinska University Hospital Huddinge, Stockholm, Sweden.; Division of Lung and Airway Research, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden., Braunstahl GJ; Franciscus Gasthuis and Vlietland Hospital, Rotterdam, The Netherlands.; Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands., Conemans LH; Maastricht Universitair Medisch Centrum+, Maastricht, The Netherlands., Lombardi F; Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy., Mathioudakis AG; Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.; North West Lung Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK., Pobeha P; Faculty of Medicine, Pavol Jozef Safarik University, Kosice, Slovakia., Ricciardolo FLM; Department of Clinical and Biological Sciences, University of Turin, Turin, Italy.; Institute of Translational Pharmacology, National Research Council (IFT-CNR), Palermo, Italy., Prada Romero LP; Neumóloga en Fundación Neumológica Colombiana Bogotá, Bogotá, Colombia., Schleich F; Respiratory Medicine, CHU Sart-Tilman B35, University of Liège, GIGA I3, Liège, Belgium., Snelgrove RJ; National Heart and Lung Institute, Imperial College London, London, UK., Trinkmann F; Department of Pneumology and Critical Care Medicine, Thoraxklinik at Heidelberg University Hospital, Translational Lung Research Center Heidelberg, German Center for Lung Research (DZL), Heidelberg, Germany.; Department of Biomedical Informatics, Center for Preventive Medicine and Digital Health, University Medical Center Mannheim, Heidelberg University, Mannheim, Germany., Uller L; Department of Experimental Medical Science, Unit of Respiratory Immunopharmacology, Lund University, Lund, Sweden., Beech A; Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.; Medicines Evaluation Unit, Manchester University NHS Foundation Trust, Manchester, UK.
Jazyk:	angličtina
Zdroj:	ERJ open research [ERJ Open Res] 2024 Mar 25; Vol. 10 (2). Date of Electronic Publication: 2024 Mar 25 (Print Publication: 2024).
DOI:	10.1183/23120541.00891-2023
Abstrakt:	In this review, early career and senior members of Assembly 5 (Airway Diseases, Asthma, COPD and Chronic Cough) present key recent findings pertinent to airway diseases that were presented during the European Respiratory Society International Congress 2023 in Milan, Italy, with a particular focus on asthma, COPD, chronic cough and bronchiectasis. During the congress, an increased number of symposia, workshops and abstract presentations were organised. In total, 739 abstracts were submitted for Assembly 5 and the majority of these were presented by early career members. These data highlight the increased interest in this group of respiratory diseases. Competing Interests: Conflict of interest: A. Bossios reports grants from the Swedish Heart–Lung Foundation and lecture honoraria to his institution, not related to this manuscript. Conflict of interest: G-J. Braunstahl reports honoraria for lectures and consultancy from GlaxoSmithKline, AstraZeneca, Novartis and Sanofi Genzyme, as well as research grants from Sanofi Genzyme, GlaxoSmithKline and AstraZeneca, not related to this manuscript. Conflict of interest: L.H. Conemans reports honoraria from GlaxoSmithKline, Sanofi, AstraZeneca and Vertex, as well as travel support from TEVA and Novartis. Conflict of interest: A.G. Mathioudakis reports lecture fees from GlaxoSmithKline. Conflict of interest: P. Pobeha reports consulting fees from Pfizer; consulting fees and honoraria from Chiesi, Angeliny and Boehringer Ingelheim; and honoraria from Berlin-Chemie. Conflict of interest: F.L.M. Ricciardolo reports grants from Chiesi, Sanofi and GlaxoSmithKline; consulting fees and honoraria from Sanofi Novartis and GlaxoSmithKline; and personal fees from AstraZeneca, Sanofi, GlaxoSmithKline and Novartis. Conflict of interest: F. Schleich reports grants, consulting fees and honoraria from Chiesi, AstraZeneca, GlaxoSmithKline and Novartis, as well as grants and consulting fees from TEVA. Conflict of interest: R.J. Snelgrove reports grants from The Wellcome Trust, Rosetrees Trust and The Stoneygate Trust. Conflict of interest: F. Trinkmann reports grants from AstraZeneca, Bayer Boehringer Ingelheim, Chiesi, Novartis, Roche, BMBF, DZL, Markedsmodningsfonden and E+H Knorr Stiftung; consulting fees and honoraria from AstraZeneca, Berlin-Chemie, Boehringer Ingelheim, Bristol-Myers Squibb, Chiesi, Fisher and Paykel, GlaxoSmithKline, Janssen-Cilag, Merck Healthcare, Novartis, Omron, OM-Pharma, Roche, Sanofi, Aventis and Thorasys; and travel support from AstraZeneca, Actelion, Bayer, Berlin-Chemie, Boehringer Ingelheim, Chiesi, Mundipharma, Novartis, Pfizer and TEVA. Conflict of interest: L. Uller reports lecture fees from AstraZeneca. Conflict of interest: L. Bergantini, J. Baker, F. Lombardi, L.P. Prada Romero and A. Beech have no conflicts of interest. (Copyright ©The authors 2024.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu